Iovance Biotherapeutics
Show contact
Links
Previous companies
Frederick G. Vogt
Interim CEO, President & General Counsel
Sean Rocca
Executive Counsel
Howard B. Johnson
Chief Business Officer
Jim Ziegler
EVP, Commercial
Kevin Smyth
SVP, Quality
+ 17 more
July, 2021 - present
November, 2019
View in org chart
